Gene Symbol | Gene ID | Gene Info |
---|---|---|
Zbtb3
|
ENSMUSG00000071661.6 | zinc finger and BTB domain containing 3 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr19_8802639_8803126 | Zbtb3 | 327 | 0.624998 | 0.13 | 3.6e-01 | Click! |
chr19_8801913_8802549 | Zbtb3 | 324 | 0.627149 | -0.07 | 6.0e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr16_16561093_16561486 | 114.99 |
Fgd4 |
FYVE, RhoGEF and PH domain containing 4 |
1070 |
0.53 |
chr13_3898122_3898458 | 45.60 |
Gm47813 |
predicted gene, 47813 |
1958 |
0.22 |
chr8_105320451_105321442 | 40.90 |
Lrrc29 |
leucine rich repeat containing 29 |
5313 |
0.07 |
chr10_81559146_81561402 | 24.45 |
Tle5 |
TLE family member 5, transcriptional modulator |
770 |
0.38 |
chr13_3898467_3898706 | 18.66 |
Gm47813 |
predicted gene, 47813 |
1662 |
0.25 |
chr5_104102748_104103400 | 17.76 |
Gm26703 |
predicted gene, 26703 |
6143 |
0.13 |
chr19_61225302_61226760 | 17.21 |
Csf2ra |
colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage) |
541 |
0.67 |
chr17_6021554_6021727 | 13.05 |
Synj2 |
synaptojanin 2 |
3436 |
0.21 |
chr7_44593726_44594565 | 13.04 |
Kcnc3 |
potassium voltage gated channel, Shaw-related subfamily, member 3 |
150 |
0.87 |
chr6_124768348_124768568 | 12.95 |
Eno2 |
enolase 2, gamma neuronal |
82 |
0.9 |
chr8_47218091_47218404 | 12.93 |
Stox2 |
storkhead box 2 |
1946 |
0.35 |
chr16_20589687_20589897 | 12.50 |
Vwa5b2 |
von Willebrand factor A domain containing 5B2 |
59 |
0.88 |
chr12_29871996_29872873 | 12.29 |
Myt1l |
myelin transcription factor 1-like |
20886 |
0.24 |
chr9_83805237_83805400 | 12.20 |
Elovl4 |
elongation of very long chain fatty acids (FEN1/Elo2, SUR4/Elo3, yeast)-like 4 |
934 |
0.6 |
chr18_43391530_43392018 | 12.19 |
Dpysl3 |
dihydropyrimidinase-like 3 |
1603 |
0.44 |
chr17_35836572_35837313 | 12.12 |
Tubb5 |
tubulin, beta 5 class I |
118 |
0.89 |
chrX_73064116_73064579 | 11.93 |
Pnma3 |
paraneoplastic antigen MA3 |
440 |
0.69 |
chr17_64131323_64131489 | 11.80 |
Pja2 |
praja ring finger ubiquitin ligase 2 |
181625 |
0.03 |
chr6_47228750_47229021 | 11.55 |
Cntnap2 |
contactin associated protein-like 2 |
15502 |
0.28 |
chr4_102534441_102534633 | 11.41 |
Pde4b |
phosphodiesterase 4B, cAMP specific |
35558 |
0.23 |
chr4_20777672_20778960 | 11.39 |
Nkain3 |
Na+/K+ transporting ATPase interacting 3 |
251 |
0.96 |
chr13_84285225_84285539 | 11.07 |
Gm46432 |
predicted gene, 46432 |
3566 |
0.21 |
chr3_14875595_14876010 | 10.96 |
Car3 |
carbonic anhydrase 3 |
6624 |
0.19 |
chr1_173367824_173368059 | 10.92 |
Cadm3 |
cell adhesion molecule 3 |
246 |
0.91 |
chr2_69020727_69020896 | 10.82 |
Gm38377 |
predicted gene, 38377 |
2715 |
0.22 |
chr2_59285656_59285855 | 10.79 |
Pkp4 |
plakophilin 4 |
19571 |
0.22 |
chr1_38847964_38848149 | 10.69 |
Lonrf2 |
LON peptidase N-terminal domain and ring finger 2 |
11345 |
0.16 |
chr5_38158989_38159808 | 10.57 |
Nsg1 |
neuron specific gene family member 1 |
7 |
0.97 |
chr16_89530496_89531006 | 10.52 |
Krtap7-1 |
keratin associated protein 7-1 |
22428 |
0.15 |
chr1_42877296_42877582 | 10.46 |
Mrps9 |
mitochondrial ribosomal protein S9 |
10298 |
0.19 |
chr7_62231071_62231594 | 10.28 |
Gm9801 |
predicted gene 9801 |
21853 |
0.21 |
chr15_98952083_98952451 | 10.21 |
Gm49450 |
predicted gene, 49450 |
1284 |
0.2 |
chr3_88230737_88231417 | 10.17 |
Gm3764 |
predicted gene 3764 |
2294 |
0.13 |
chr10_106632222_106632491 | 10.09 |
4930532I03Rik |
RIKEN cDNA 4930532I03 gene |
29876 |
0.23 |
chr9_75625075_75626579 | 10.01 |
Lysmd2 |
LysM, putative peptidoglycan-binding, domain containing 2 |
68 |
0.96 |
chr1_176355187_176355657 | 9.98 |
Gm17965 |
predicted gene, 17965 |
15779 |
0.19 |
chr6_51848532_51848712 | 9.96 |
Skap2 |
src family associated phosphoprotein 2 |
23307 |
0.22 |
chr19_42673147_42673532 | 9.89 |
Gm25216 |
predicted gene, 25216 |
26563 |
0.16 |
chr13_83721104_83721451 | 9.81 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
104 |
0.95 |
chrX_105391659_105392013 | 9.65 |
5330434G04Rik |
RIKEN cDNA 5330434G04 gene |
60 |
0.97 |
chr13_34133643_34133908 | 9.64 |
Gm36500 |
predicted gene, 36500 |
85 |
0.94 |
chr10_49783263_49783766 | 9.63 |
Grik2 |
glutamate receptor, ionotropic, kainate 2 (beta 2) |
105 |
0.96 |
chr16_28752665_28752856 | 9.62 |
Fgf12 |
fibroblast growth factor 12 |
308 |
0.94 |
chr2_34486214_34486378 | 9.62 |
Mapkap1 |
mitogen-activated protein kinase associated protein 1 |
41949 |
0.13 |
chr12_61526290_61526584 | 9.60 |
Lrfn5 |
leucine rich repeat and fibronectin type III domain containing 5 |
2489 |
0.28 |
chr6_126768206_126768472 | 9.57 |
Kcna6 |
potassium voltage-gated channel, shaker-related, subfamily, member 6 |
27665 |
0.13 |
chr6_146402013_146402164 | 9.43 |
Itpr2 |
inositol 1,4,5-triphosphate receptor 2 |
5102 |
0.23 |
chr7_84372464_84372615 | 9.42 |
Arnt2 |
aryl hydrocarbon receptor nuclear translocator 2 |
8 |
0.98 |
chr7_49870383_49870534 | 9.41 |
Slc6a5 |
solute carrier family 6 (neurotransmitter transporter, glycine), member 5 |
39688 |
0.16 |
chr14_24618263_24618731 | 9.38 |
4930428N03Rik |
RIKEN cDNA 4930428N03 gene |
534 |
0.66 |
chr6_54433120_54433271 | 9.30 |
9130019P16Rik |
RIKEN cDNA 9130019P16 gene |
2974 |
0.23 |
chr1_143640887_143641101 | 9.20 |
B3galt2 |
UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 2 |
330 |
0.56 |
chr8_65617940_65618821 | 9.18 |
Marchf1 |
membrane associated ring-CH-type finger 1 |
145 |
0.97 |
chr7_109039547_109039721 | 9.13 |
Tub |
tubby bipartite transcription factor |
12411 |
0.15 |
chr6_141568677_141568868 | 9.12 |
Slco1c1 |
solute carrier organic anion transporter family, member 1c1 |
22608 |
0.23 |
chr5_99597850_99598001 | 9.12 |
Gm16228 |
predicted gene 16228 |
13508 |
0.17 |
chr5_33995599_33996957 | 9.10 |
Nat8l |
N-acetyltransferase 8-like |
294 |
0.82 |
chr18_34248337_34248508 | 9.04 |
Apc |
APC, WNT signaling pathway regulator |
724 |
0.67 |
chr1_38835547_38836894 | 8.99 |
Lonrf2 |
LON peptidase N-terminal domain and ring finger 2 |
154 |
0.95 |
chr3_85300020_85300198 | 8.97 |
1700036G14Rik |
RIKEN cDNA 1700036G14 gene |
17410 |
0.24 |
chr9_25378508_25378723 | 8.94 |
Gm18891 |
predicted gene, 18891 |
29117 |
0.17 |
chr10_29143863_29144732 | 8.89 |
Gm9996 |
predicted gene 9996 |
103 |
0.69 |
chr2_142187506_142187741 | 8.84 |
Macrod2 |
mono-ADP ribosylhydrolase 2 |
11016 |
0.32 |
chr10_32889642_32890523 | 8.77 |
Nkain2 |
Na+/K+ transporting ATPase interacting 2 |
234 |
0.95 |
chr4_32479919_32480224 | 8.69 |
Bach2 |
BTB and CNC homology, basic leucine zipper transcription factor 2 |
21434 |
0.22 |
chr3_104058968_104059448 | 8.67 |
Gm42696 |
predicted gene 42696 |
1067 |
0.33 |
chr8_12126295_12126640 | 8.62 |
A230072I06Rik |
RIKEN cDNA A230072I06 gene |
152352 |
0.03 |
chr8_108481367_108481751 | 8.61 |
Gm39244 |
predicted gene, 39244 |
55388 |
0.16 |
chr2_63452968_63453186 | 8.57 |
Gm23503 |
predicted gene, 23503 |
20883 |
0.24 |
chr2_173023232_173024333 | 8.48 |
Rbm38 |
RNA binding motif protein 38 |
732 |
0.4 |
chr4_131253013_131253195 | 8.46 |
Gm25261 |
predicted gene, 25261 |
13827 |
0.28 |
chr13_29274417_29274591 | 8.45 |
Gm11364 |
predicted gene 11364 |
37884 |
0.21 |
chr19_20923414_20923594 | 8.45 |
Gm32750 |
predicted gene, 32750 |
1112 |
0.59 |
chr12_73334058_73334213 | 8.43 |
Slc38a6 |
solute carrier family 38, member 6 |
10232 |
0.17 |
chr16_20589380_20589667 | 8.36 |
Vwa5b2 |
von Willebrand factor A domain containing 5B2 |
52 |
0.9 |
chr7_64533404_64533751 | 8.35 |
Gm44721 |
predicted gene 44721 |
4152 |
0.22 |
chr13_107541517_107541668 | 8.34 |
Gm32004 |
predicted gene, 32004 |
23731 |
0.2 |
chr19_21742139_21742471 | 8.33 |
Gm50129 |
predicted gene, 50129 |
13035 |
0.2 |
chr3_16431457_16431615 | 8.32 |
Ythdf3 |
YTH N6-methyladenosine RNA binding protein 3 |
248300 |
0.02 |
chr18_33462404_33462669 | 8.30 |
Nrep |
neuronal regeneration related protein |
899 |
0.54 |
chr1_119049949_119050658 | 8.29 |
Gli2 |
GLI-Kruppel family member GLI2 |
3036 |
0.28 |
chr1_191224278_191225037 | 8.28 |
D730003I15Rik |
RIKEN cDNA D730003I15 gene |
183 |
0.92 |
chr5_26991582_26992107 | 8.27 |
Gm16057 |
predicted gene 16057 |
15777 |
0.25 |
chr9_57901684_57901878 | 8.21 |
Ubl7 |
ubiquitin-like 7 (bone marrow stromal cell-derived) |
9198 |
0.17 |
chr12_49398841_49398992 | 8.20 |
3110039M20Rik |
RIKEN cDNA 3110039M20 gene |
8257 |
0.13 |
chr10_58227289_58228680 | 8.17 |
Gm10807 |
predicted gene 10807 |
667 |
0.56 |
chr3_29689988_29690160 | 8.17 |
Mir21b |
microRNA 21b |
53330 |
0.15 |
chr15_64920763_64921549 | 8.15 |
Adcy8 |
adenylate cyclase 8 |
1115 |
0.61 |
chr14_66910808_66911486 | 8.11 |
Pnma2 |
paraneoplastic antigen MA2 |
23 |
0.97 |
chr13_8731478_8731629 | 8.09 |
Adarb2 |
adenosine deaminase, RNA-specific, B2 |
26776 |
0.17 |
chr17_72505215_72505607 | 8.08 |
Gm24736 |
predicted gene, 24736 |
5993 |
0.25 |
chr4_116016940_116018214 | 8.05 |
Faah |
fatty acid amide hydrolase |
98 |
0.95 |
chr14_124677301_124677726 | 8.04 |
Fgf14 |
fibroblast growth factor 14 |
386 |
0.9 |
chr7_130692342_130693149 | 8.04 |
Tacc2 |
transforming, acidic coiled-coil containing protein 2 |
20 |
0.98 |
chr18_12643212_12644484 | 8.04 |
Ttc39c |
tetratricopeptide repeat domain 39C |
486 |
0.46 |
chr11_20987831_20988009 | 8.04 |
Gm23681 |
predicted gene, 23681 |
50219 |
0.13 |
chr11_71758404_71758886 | 7.93 |
Wscd1 |
WSC domain containing 1 |
7269 |
0.18 |
chr5_150905805_150906370 | 7.92 |
Gm43298 |
predicted gene 43298 |
23445 |
0.17 |
chr14_75455687_75456060 | 7.89 |
Siah3 |
siah E3 ubiquitin protein ligase family member 3 |
109 |
0.97 |
chr8_12873206_12874084 | 7.88 |
Mcf2l |
mcf.2 transforming sequence-like |
161 |
0.92 |
chr3_55423703_55423867 | 7.81 |
Gm42609 |
predicted gene 42609 |
20663 |
0.15 |
chr5_149513472_149514426 | 7.81 |
Gm2566 |
predicted gene 2566 |
10897 |
0.13 |
chr3_116007285_116008437 | 7.79 |
Extl2 |
exostosin-like glycosyltransferase 2 |
33 |
0.88 |
chr4_19569392_19570378 | 7.78 |
Cpne3 |
copine III |
198 |
0.94 |
chr9_58440192_58440377 | 7.78 |
4930461G14Rik |
RIKEN cDNA 4930461G14 gene |
14838 |
0.17 |
chr3_66325480_66326023 | 7.74 |
Veph1 |
ventricular zone expressed PH domain-containing 1 |
28914 |
0.18 |
chr15_88315161_88315318 | 7.74 |
B230214G05Rik |
RIKEN cDNA B230214G05 gene |
365 |
0.51 |
chr17_15248204_15248393 | 7.74 |
Gm5091 |
predicted gene 5091 |
381 |
0.87 |
chr4_24429638_24429836 | 7.73 |
Gm27243 |
predicted gene 27243 |
1153 |
0.54 |
chr14_55054195_55054444 | 7.73 |
Zfhx2os |
zinc finger homeobox 2, opposite strand |
372 |
0.55 |
chr16_37676518_37676692 | 7.73 |
Gm4600 |
predicted gene 4600 |
20735 |
0.15 |
chr14_71963403_71963695 | 7.70 |
4930434J06Rik |
RIKEN cDNA 4930434J06 gene |
50458 |
0.18 |
chr3_108568662_108568847 | 7.69 |
Gm22860 |
predicted gene, 22860 |
1371 |
0.21 |
chr14_19977078_19977720 | 7.68 |
Gng2 |
guanine nucleotide binding protein (G protein), gamma 2 |
150 |
0.96 |
chr2_45225367_45225747 | 7.64 |
Gm28643 |
predicted gene 28643 |
68632 |
0.11 |
chr6_146402192_146402397 | 7.63 |
Itpr2 |
inositol 1,4,5-triphosphate receptor 2 |
5308 |
0.23 |
chr8_87836611_87837241 | 7.59 |
Zfp423 |
zinc finger protein 423 |
32487 |
0.22 |
chr5_108549866_108550582 | 7.58 |
Cplx1 |
complexin 1 |
200 |
0.9 |
chr17_9579512_9579944 | 7.58 |
Gm49807 |
predicted gene, 49807 |
30037 |
0.21 |
chr3_51590575_51590969 | 7.55 |
5430433H01Rik |
RIKEN cDNA 5430433H01 gene |
8466 |
0.11 |
chr15_89499752_89500815 | 7.54 |
Shank3 |
SH3 and multiple ankyrin repeat domains 3 |
160 |
0.9 |
chr1_157798948_157799099 | 7.46 |
Gm38256 |
predicted gene, 38256 |
141362 |
0.04 |
chr3_63616179_63616468 | 7.46 |
Plch1 |
phospholipase C, eta 1 |
85720 |
0.08 |
chr6_55676658_55677265 | 7.45 |
Neurod6 |
neurogenic differentiation 6 |
4302 |
0.26 |
chr4_124862200_124862378 | 7.43 |
Maneal |
mannosidase, endo-alpha-like |
118 |
0.93 |
chr1_132766191_132766371 | 7.39 |
Nfasc |
neurofascin |
24484 |
0.16 |
chr16_35587590_35588108 | 7.31 |
Gm5963 |
predicted pseudogene 5963 |
14293 |
0.18 |
chr6_28842333_28842923 | 7.31 |
Snd1 |
staphylococcal nuclease and tudor domain containing 1 |
6279 |
0.2 |
chr15_88978956_88979127 | 7.29 |
Mlc1 |
megalencephalic leukoencephalopathy with subcortical cysts 1 homolog (human) |
34 |
0.95 |
chr14_124674932_124675664 | 7.28 |
Fgf14 |
fibroblast growth factor 14 |
1829 |
0.42 |
chr4_35927828_35928008 | 7.27 |
Gm12369 |
predicted gene 12369 |
76261 |
0.11 |
chr8_84945228_84946066 | 7.27 |
Rtbdn |
retbindin |
1344 |
0.18 |
chr4_40064530_40064723 | 7.27 |
Gm12388 |
predicted gene 12388 |
4475 |
0.24 |
chr11_57531390_57531560 | 7.24 |
Mfap3 |
microfibrillar-associated protein 3 |
8511 |
0.18 |
chr11_93098185_93098336 | 7.23 |
Car10 |
carbonic anhydrase 10 |
144 |
0.98 |
chr8_33992574_33993302 | 7.23 |
Gm45817 |
predicted gene 45817 |
5738 |
0.17 |
chr15_8659976_8660428 | 7.20 |
Gm37310 |
predicted gene, 37310 |
5129 |
0.23 |
chr13_51568764_51569283 | 7.20 |
Shc3 |
src homology 2 domain-containing transforming protein C3 |
396 |
0.88 |
chr13_116497636_116498069 | 7.19 |
Gm47912 |
predicted gene, 47912 |
136158 |
0.05 |
chr13_96132470_96133258 | 7.17 |
Sv2c |
synaptic vesicle glycoprotein 2c |
287 |
0.67 |
chr18_36017856_36019112 | 7.17 |
Nrg2 |
neuregulin 2 |
13457 |
0.16 |
chr15_76517232_76517738 | 7.17 |
Scrt1 |
scratch family zinc finger 1 |
4417 |
0.08 |
chr4_103621249_103621400 | 7.16 |
Dab1 |
disabled 1 |
1659 |
0.37 |
chr12_45561898_45562268 | 7.15 |
Gm48517 |
predicted gene, 48517 |
11204 |
0.27 |
chr6_86028930_86029334 | 7.14 |
Add2 |
adducin 2 (beta) |
385 |
0.76 |
chr11_45577771_45577981 | 7.12 |
Gm22284 |
predicted gene, 22284 |
61507 |
0.13 |
chr4_31493256_31493504 | 7.11 |
Gm11922 |
predicted gene 11922 |
112908 |
0.07 |
chr14_3208167_3209194 | 7.09 |
D830030K20Rik |
RIKEN cDNA D830030K20 gene |
103 |
0.95 |
chr2_22627392_22627559 | 7.07 |
Gad2 |
glutamic acid decarboxylase 2 |
4171 |
0.16 |
chr12_3238767_3239202 | 7.06 |
Rab10os |
RAB10, member RAS oncogene family, opposite strand |
2373 |
0.24 |
chr5_128952966_128953137 | 7.05 |
Rimbp2 |
RIMS binding protein 2 |
4 |
0.98 |
chr3_16811226_16811377 | 7.04 |
Gm26485 |
predicted gene, 26485 |
12011 |
0.32 |
chr3_4798339_4798490 | 7.04 |
1110015O18Rik |
RIKEN cDNA 1110015O18 gene |
294 |
0.93 |
chr14_108910807_108911318 | 7.03 |
Slitrk1 |
SLIT and NTRK-like family, member 1 |
3096 |
0.41 |
chr15_44787967_44788147 | 7.03 |
Sybu |
syntabulin (syntaxin-interacting) |
6 |
0.8 |
chr6_81817386_81817585 | 7.00 |
Gm22530 |
predicted gene, 22530 |
10694 |
0.16 |
chr15_12093297_12093665 | 6.99 |
Gm34759 |
predicted gene, 34759 |
8284 |
0.16 |
chr2_41470719_41470900 | 6.99 |
Lrp1b |
low density lipoprotein-related protein 1B |
318269 |
0.01 |
chr1_56750026_56750177 | 6.99 |
Hsfy2 |
heat shock transcription factor, Y-linked 2 |
112666 |
0.07 |
chr4_154499598_154500103 | 6.97 |
Prdm16 |
PR domain containing 16 |
28915 |
0.17 |
chr9_86743527_86743928 | 6.97 |
Prss35 |
protease, serine 35 |
78 |
0.96 |
chr1_120817619_120817784 | 6.95 |
Gm29345 |
predicted gene 29345 |
1201 |
0.42 |
chr16_62537806_62537980 | 6.94 |
Gm24164 |
predicted gene, 24164 |
33143 |
0.18 |
chr19_22518652_22518803 | 6.92 |
Gm27151 |
predicted gene 27151 |
69862 |
0.11 |
chr4_85707330_85707812 | 6.90 |
Adamtsl1 |
ADAMTS-like 1 |
193244 |
0.03 |
chr12_12725111_12725688 | 6.89 |
3732407C23Rik |
RIKEN cDNA 3732407C23 gene |
2538 |
0.26 |
chr17_91090761_91090912 | 6.89 |
Nrxn1 |
neurexin I |
1897 |
0.25 |
chr18_71595284_71595456 | 6.89 |
Gm50262 |
predicted gene, 50262 |
687719 |
0.0 |
chr1_18057766_18058108 | 6.86 |
Gm45784 |
predicted gene 45784 |
332 |
0.76 |
chr11_19554563_19554970 | 6.86 |
Gm12027 |
predicted gene 12027 |
73295 |
0.11 |
chr10_57848326_57848595 | 6.84 |
Smpdl3a |
sphingomyelin phosphodiesterase, acid-like 3A |
53892 |
0.13 |
chr4_149220099_149220294 | 6.80 |
Kif1b |
kinesin family member 1B |
3322 |
0.22 |
chr1_81593672_81593857 | 6.79 |
Gm6198 |
predicted gene 6198 |
36281 |
0.2 |
chr2_14740459_14740624 | 6.79 |
Gm10848 |
predicted gene 10848 |
819 |
0.37 |
chr16_17277832_17278420 | 6.78 |
Tmem191c |
transmembrane protein 191C |
525 |
0.65 |
chr12_108333504_108334768 | 6.77 |
Cyp46a1 |
cytochrome P450, family 46, subfamily a, polypeptide 1 |
245 |
0.91 |
chrX_60545622_60545821 | 6.75 |
Gm715 |
predicted gene 715 |
2298 |
0.23 |
chr2_123813197_123813966 | 6.74 |
Sema6d |
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D |
276388 |
0.02 |
chr6_36880973_36881293 | 6.74 |
1700111E14Rik |
RIKEN cDNA 1700111E14 gene |
55915 |
0.13 |
chr16_56057278_56057429 | 6.73 |
Senp7 |
SUMO1/sentrin specific peptidase 7 |
9015 |
0.11 |
chr12_32926365_32926853 | 6.73 |
Gm19056 |
predicted gene, 19056 |
3338 |
0.15 |
chr1_34097758_34097909 | 6.72 |
Dst |
dystonin |
8541 |
0.18 |
chr16_35598799_35599049 | 6.71 |
Gm5963 |
predicted pseudogene 5963 |
25368 |
0.17 |
chr11_31941716_31941901 | 6.70 |
4930524B15Rik |
RIKEN cDNA 4930524B15 gene |
23784 |
0.18 |
chr8_10153565_10153926 | 6.70 |
Myo16 |
myosin XVI |
166 |
0.97 |
chr6_127766618_127766811 | 6.70 |
Gm42738 |
predicted gene 42738 |
828 |
0.43 |
chr18_25016903_25017067 | 6.69 |
Fhod3 |
formin homology 2 domain containing 3 |
107376 |
0.07 |
chr3_147443056_147443207 | 6.69 |
Gm37041 |
predicted gene, 37041 |
14242 |
0.22 |
chr1_169462847_169463063 | 6.68 |
Gm5265 |
predicted pseudogene 5265 |
9086 |
0.25 |
chr13_37311739_37312557 | 6.68 |
Gm47711 |
predicted gene, 47711 |
14318 |
0.16 |
chr4_142336961_142337112 | 6.65 |
Gm13052 |
predicted gene 13052 |
9439 |
0.27 |
chr2_105690434_105690620 | 6.64 |
Pax6 |
paired box 6 |
1956 |
0.29 |
chr16_35592451_35593042 | 6.59 |
Gm5963 |
predicted pseudogene 5963 |
19190 |
0.18 |
chr14_71249500_71249731 | 6.58 |
Gm4251 |
predicted gene 4251 |
1658 |
0.51 |
chr10_39506868_39507159 | 6.58 |
Fyn |
Fyn proto-oncogene |
4726 |
0.24 |
chr12_3234876_3235557 | 6.57 |
Rab10os |
RAB10, member RAS oncogene family, opposite strand |
288 |
0.88 |
chr8_41053806_41053970 | 6.57 |
Gm16193 |
predicted gene 16193 |
778 |
0.43 |
chr1_59789089_59789274 | 6.54 |
Gm38125 |
predicted gene, 38125 |
12082 |
0.15 |
chr5_77838281_77838447 | 6.54 |
Gm42673 |
predicted gene 42673 |
71096 |
0.12 |
chr1_6761310_6761539 | 6.54 |
St18 |
suppression of tumorigenicity 18 |
23849 |
0.23 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
17.4 | 69.4 | GO:0030035 | microspike assembly(GO:0030035) |
5.6 | 16.7 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
4.6 | 18.4 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
4.5 | 13.4 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
3.3 | 9.8 | GO:0021564 | vagus nerve development(GO:0021564) |
3.2 | 15.8 | GO:0098596 | vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
2.7 | 8.0 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
2.6 | 18.4 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
2.6 | 23.7 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
2.5 | 7.6 | GO:0051586 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
2.5 | 7.4 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
2.4 | 7.1 | GO:0030070 | insulin processing(GO:0030070) |
2.1 | 6.3 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
2.1 | 6.3 | GO:0033058 | directional locomotion(GO:0033058) |
2.1 | 14.5 | GO:0016198 | axon choice point recognition(GO:0016198) |
2.0 | 4.1 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
2.0 | 4.0 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
2.0 | 5.9 | GO:1903802 | L-glutamate(1-) import into cell(GO:1903802) L-glutamate import into cell(GO:1990123) |
1.9 | 9.7 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
1.9 | 5.8 | GO:0044337 | canonical Wnt signaling pathway involved in positive regulation of apoptotic process(GO:0044337) |
1.9 | 5.6 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
1.9 | 7.4 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
1.9 | 5.6 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
1.7 | 5.0 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
1.7 | 5.0 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
1.6 | 6.5 | GO:0098910 | regulation of atrial cardiac muscle cell action potential(GO:0098910) |
1.6 | 6.5 | GO:0061110 | dense core granule biogenesis(GO:0061110) |
1.6 | 4.8 | GO:0030910 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
1.6 | 6.3 | GO:0051612 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
1.6 | 4.7 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
1.5 | 6.2 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
1.5 | 4.4 | GO:0061346 | non-canonical Wnt signaling pathway involved in heart development(GO:0061341) planar cell polarity pathway involved in heart morphogenesis(GO:0061346) |
1.5 | 3.0 | GO:1900157 | regulation of bone mineralization involved in bone maturation(GO:1900157) |
1.5 | 7.4 | GO:0010519 | negative regulation of phospholipase activity(GO:0010519) |
1.5 | 5.8 | GO:0060486 | Clara cell differentiation(GO:0060486) |
1.4 | 5.8 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
1.4 | 1.4 | GO:1904861 | excitatory synapse assembly(GO:1904861) |
1.4 | 17.7 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
1.3 | 2.7 | GO:0099612 | protein localization to paranode region of axon(GO:0002175) protein localization to axon(GO:0099612) |
1.3 | 11.8 | GO:0071625 | vocalization behavior(GO:0071625) |
1.3 | 7.9 | GO:0046069 | cGMP catabolic process(GO:0046069) |
1.3 | 7.9 | GO:0003357 | noradrenergic neuron differentiation(GO:0003357) |
1.3 | 11.7 | GO:0021554 | optic nerve development(GO:0021554) |
1.3 | 3.9 | GO:0060618 | nipple development(GO:0060618) |
1.3 | 3.8 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
1.3 | 5.1 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
1.3 | 11.3 | GO:0097120 | receptor localization to synapse(GO:0097120) |
1.2 | 4.7 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
1.2 | 5.9 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
1.2 | 3.5 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
1.2 | 7.0 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
1.2 | 6.9 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
1.2 | 5.8 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
1.1 | 9.1 | GO:0071420 | cellular response to histamine(GO:0071420) |
1.1 | 3.4 | GO:0014029 | neural crest formation(GO:0014029) |
1.1 | 3.4 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
1.1 | 13.4 | GO:0048268 | clathrin coat assembly(GO:0048268) |
1.1 | 1.1 | GO:1900451 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
1.1 | 6.7 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
1.1 | 3.3 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
1.1 | 3.3 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
1.1 | 2.2 | GO:0048880 | sensory system development(GO:0048880) |
1.1 | 6.4 | GO:0003025 | regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
1.1 | 5.3 | GO:0033762 | response to glucagon(GO:0033762) |
1.1 | 2.1 | GO:0072025 | distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) metanephric DCT cell differentiation(GO:0072240) |
1.1 | 4.3 | GO:0001806 | type IV hypersensitivity(GO:0001806) |
1.1 | 6.4 | GO:0060923 | cardiac muscle cell fate commitment(GO:0060923) |
1.1 | 7.4 | GO:0021684 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
1.0 | 3.1 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
1.0 | 4.2 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
1.0 | 1.0 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
1.0 | 1.0 | GO:1904339 | negative regulation of dopaminergic neuron differentiation(GO:1904339) |
1.0 | 4.1 | GO:0061055 | myotome development(GO:0061055) |
1.0 | 4.1 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
1.0 | 7.1 | GO:0019368 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
1.0 | 9.1 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
1.0 | 10.0 | GO:0015816 | glycine transport(GO:0015816) |
1.0 | 2.0 | GO:0018992 | germ-line sex determination(GO:0018992) |
1.0 | 3.0 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
1.0 | 9.8 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
1.0 | 5.9 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
1.0 | 7.8 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
1.0 | 2.9 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
1.0 | 2.9 | GO:0061743 | motor learning(GO:0061743) |
1.0 | 7.6 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.9 | 2.8 | GO:0048296 | isotype switching to IgA isotypes(GO:0048290) regulation of isotype switching to IgA isotypes(GO:0048296) |
0.9 | 0.9 | GO:0050748 | negative regulation of lipoprotein metabolic process(GO:0050748) |
0.9 | 3.8 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
0.9 | 4.7 | GO:0032252 | secretory granule localization(GO:0032252) |
0.9 | 3.7 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.9 | 2.8 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.9 | 1.9 | GO:2000598 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.9 | 1.9 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
0.9 | 4.6 | GO:0032229 | negative regulation of synaptic transmission, GABAergic(GO:0032229) |
0.9 | 4.5 | GO:0060120 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.9 | 7.1 | GO:0051451 | myoblast migration(GO:0051451) |
0.9 | 3.5 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.9 | 3.5 | GO:0021681 | cerebellar granular layer development(GO:0021681) |
0.9 | 15.4 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.8 | 14.4 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.8 | 0.8 | GO:0090191 | negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
0.8 | 1.7 | GO:0061031 | endodermal digestive tract morphogenesis(GO:0061031) |
0.8 | 0.8 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
0.8 | 2.5 | GO:0042851 | L-alanine metabolic process(GO:0042851) |
0.8 | 3.3 | GO:1904849 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
0.8 | 3.3 | GO:0046909 | intermembrane transport(GO:0046909) |
0.8 | 1.6 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) |
0.8 | 2.4 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.8 | 3.2 | GO:0090427 | activation of meiosis(GO:0090427) |
0.8 | 3.2 | GO:0021747 | cochlear nucleus development(GO:0021747) |
0.8 | 1.6 | GO:0060596 | mammary placode formation(GO:0060596) |
0.8 | 5.6 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.8 | 3.2 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.8 | 3.2 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.8 | 1.6 | GO:0031635 | adenylate cyclase-inhibiting opioid receptor signaling pathway(GO:0031635) |
0.8 | 3.9 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.8 | 1.6 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.8 | 4.7 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
0.8 | 5.4 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
0.8 | 3.9 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.8 | 3.1 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.8 | 1.5 | GO:0098597 | observational learning(GO:0098597) |
0.8 | 2.3 | GO:0052422 | modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.8 | 9.8 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.8 | 3.8 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.8 | 2.3 | GO:1900147 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
0.7 | 6.0 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.7 | 2.2 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.7 | 11.9 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.7 | 4.5 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
0.7 | 5.8 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.7 | 2.9 | GO:0045759 | negative regulation of action potential(GO:0045759) |
0.7 | 3.6 | GO:0046958 | nonassociative learning(GO:0046958) |
0.7 | 5.8 | GO:0099625 | regulation of ventricular cardiac muscle cell membrane repolarization(GO:0060307) ventricular cardiac muscle cell membrane repolarization(GO:0099625) |
0.7 | 0.7 | GO:0042661 | regulation of mesodermal cell fate specification(GO:0042661) |
0.7 | 2.9 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.7 | 2.9 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.7 | 2.1 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.7 | 2.1 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.7 | 2.1 | GO:0086026 | atrial cardiac muscle cell action potential(GO:0086014) atrial cardiac muscle cell to AV node cell signaling(GO:0086026) atrial cardiac muscle cell to AV node cell communication(GO:0086066) |
0.7 | 0.7 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.7 | 3.5 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
0.7 | 1.4 | GO:0031223 | auditory behavior(GO:0031223) |
0.7 | 3.5 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.7 | 2.1 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.7 | 3.4 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.7 | 0.7 | GO:0072092 | ureteric bud invasion(GO:0072092) metanephric renal vesicle formation(GO:0072093) |
0.7 | 2.0 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.7 | 1.3 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.7 | 4.0 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.7 | 2.0 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.7 | 2.0 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.7 | 0.7 | GO:0010996 | response to auditory stimulus(GO:0010996) |
0.7 | 0.7 | GO:0021764 | amygdala development(GO:0021764) |
0.7 | 5.2 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.7 | 3.3 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.7 | 2.0 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
0.7 | 0.7 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
0.7 | 4.6 | GO:0031000 | response to caffeine(GO:0031000) |
0.6 | 2.6 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
0.6 | 1.3 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.6 | 3.2 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.6 | 1.9 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.6 | 1.9 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.6 | 7.7 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.6 | 1.9 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.6 | 1.9 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.6 | 4.5 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.6 | 4.5 | GO:1902003 | regulation of beta-amyloid formation(GO:1902003) |
0.6 | 7.0 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.6 | 1.9 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
0.6 | 1.9 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) |
0.6 | 2.5 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.6 | 2.5 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.6 | 0.6 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.6 | 15.7 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.6 | 0.6 | GO:0099623 | regulation of cardiac muscle cell membrane repolarization(GO:0099623) |
0.6 | 2.5 | GO:0015824 | proline transport(GO:0015824) |
0.6 | 0.6 | GO:0010909 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.6 | 0.6 | GO:0021847 | ventricular zone neuroblast division(GO:0021847) |
0.6 | 13.0 | GO:2001258 | negative regulation of cation channel activity(GO:2001258) |
0.6 | 4.3 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.6 | 1.2 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
0.6 | 1.9 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.6 | 1.2 | GO:0042322 | negative regulation of circadian sleep/wake cycle, REM sleep(GO:0042322) |
0.6 | 4.9 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.6 | 1.8 | GO:2001025 | positive regulation of response to drug(GO:2001025) |
0.6 | 4.9 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.6 | 2.4 | GO:0042268 | regulation of cytolysis(GO:0042268) |
0.6 | 1.2 | GO:0006113 | fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
0.6 | 3.6 | GO:0042045 | epithelial fluid transport(GO:0042045) |
0.6 | 1.8 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.6 | 1.8 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.6 | 10.1 | GO:0001964 | startle response(GO:0001964) |
0.6 | 3.0 | GO:0070173 | regulation of enamel mineralization(GO:0070173) |
0.6 | 2.4 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.6 | 12.4 | GO:0007616 | long-term memory(GO:0007616) |
0.6 | 3.5 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.6 | 5.2 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.6 | 3.4 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.6 | 6.3 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.6 | 2.3 | GO:0071910 | determination of pancreatic left/right asymmetry(GO:0035469) determination of liver left/right asymmetry(GO:0071910) |
0.6 | 1.1 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.6 | 2.8 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.6 | 1.7 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
0.6 | 1.7 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.6 | 1.7 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.6 | 3.3 | GO:0022605 | oogenesis stage(GO:0022605) |
0.6 | 1.7 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.6 | 1.1 | GO:0097360 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
0.6 | 1.7 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
0.5 | 0.5 | GO:0038027 | apolipoprotein A-I-mediated signaling pathway(GO:0038027) |
0.5 | 2.1 | GO:0030091 | protein repair(GO:0030091) |
0.5 | 1.6 | GO:0032383 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.5 | 0.5 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
0.5 | 3.1 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
0.5 | 2.1 | GO:0034080 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.5 | 2.6 | GO:0014744 | positive regulation of muscle adaptation(GO:0014744) |
0.5 | 1.0 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
0.5 | 2.6 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) |
0.5 | 3.6 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.5 | 1.5 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.5 | 0.5 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.5 | 3.0 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.5 | 7.0 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.5 | 1.5 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.5 | 1.0 | GO:1900045 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
0.5 | 1.5 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.5 | 3.5 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.5 | 2.5 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.5 | 1.5 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.5 | 1.5 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.5 | 1.0 | GO:0014045 | establishment of endothelial blood-brain barrier(GO:0014045) |
0.5 | 5.2 | GO:0016048 | detection of temperature stimulus(GO:0016048) |
0.5 | 0.5 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
0.5 | 30.1 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.5 | 1.9 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.5 | 1.4 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.5 | 21.7 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.4 | 3.1 | GO:0060573 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.4 | 1.3 | GO:0070268 | cornification(GO:0070268) |
0.4 | 1.3 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.4 | 1.8 | GO:0018103 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.4 | 0.4 | GO:0021794 | thalamus development(GO:0021794) |
0.4 | 1.3 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.4 | 7.0 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
0.4 | 6.1 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
0.4 | 0.9 | GO:0042938 | dipeptide transport(GO:0042938) |
0.4 | 4.3 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.4 | 1.3 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
0.4 | 0.9 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
0.4 | 1.7 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.4 | 0.9 | GO:0035912 | dorsal aorta development(GO:0035907) dorsal aorta morphogenesis(GO:0035912) |
0.4 | 2.1 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.4 | 0.8 | GO:0014738 | regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
0.4 | 5.1 | GO:0015858 | nucleoside transport(GO:0015858) |
0.4 | 1.3 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.4 | 5.9 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.4 | 0.4 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.4 | 0.4 | GO:0003340 | negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003340) |
0.4 | 1.3 | GO:0061624 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
0.4 | 0.4 | GO:0071476 | cellular hypotonic response(GO:0071476) |
0.4 | 0.4 | GO:0097476 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
0.4 | 0.4 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.4 | 5.8 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.4 | 0.8 | GO:0060005 | vestibular reflex(GO:0060005) |
0.4 | 7.8 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.4 | 0.4 | GO:2000847 | negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
0.4 | 1.2 | GO:0034392 | negative regulation of smooth muscle cell apoptotic process(GO:0034392) |
0.4 | 8.8 | GO:0019228 | neuronal action potential(GO:0019228) |
0.4 | 0.4 | GO:0035993 | deltoid tuberosity development(GO:0035993) |
0.4 | 3.2 | GO:0032509 | endosome transport via multivesicular body sorting pathway(GO:0032509) |
0.4 | 1.6 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.4 | 2.4 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
0.4 | 2.0 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.4 | 1.6 | GO:0015822 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
0.4 | 2.4 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.4 | 0.4 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.4 | 1.2 | GO:0015755 | fructose transport(GO:0015755) |
0.4 | 0.4 | GO:0030908 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.4 | 0.8 | GO:0009629 | response to gravity(GO:0009629) |
0.4 | 1.9 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.4 | 0.4 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.4 | 5.3 | GO:0099517 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.4 | 1.5 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.4 | 0.4 | GO:0035934 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.4 | 0.7 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.4 | 1.1 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
0.4 | 1.1 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.4 | 1.5 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.4 | 1.5 | GO:0022038 | corpus callosum development(GO:0022038) |
0.4 | 2.2 | GO:0014820 | tonic smooth muscle contraction(GO:0014820) artery smooth muscle contraction(GO:0014824) |
0.4 | 0.4 | GO:0046864 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
0.4 | 1.1 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
0.4 | 2.9 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.4 | 1.4 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.4 | 1.1 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
0.4 | 0.7 | GO:0031296 | B cell costimulation(GO:0031296) |
0.4 | 1.1 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.3 | 1.7 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.3 | 1.4 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.3 | 1.0 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
0.3 | 0.7 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.3 | 1.4 | GO:0009169 | ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.3 | 5.8 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.3 | 1.4 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
0.3 | 0.3 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
0.3 | 0.7 | GO:0007525 | somatic muscle development(GO:0007525) |
0.3 | 0.7 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.3 | 3.0 | GO:0001711 | endodermal cell fate commitment(GO:0001711) |
0.3 | 0.7 | GO:0035992 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.3 | 3.7 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
0.3 | 1.3 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.3 | 1.0 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.3 | 0.3 | GO:0051788 | response to misfolded protein(GO:0051788) |
0.3 | 1.6 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.3 | 0.3 | GO:0030421 | defecation(GO:0030421) |
0.3 | 1.0 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.3 | 0.3 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.3 | 0.6 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.3 | 0.9 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.3 | 0.9 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.3 | 0.3 | GO:0042488 | positive regulation of odontogenesis of dentin-containing tooth(GO:0042488) positive regulation of glial cell migration(GO:1903977) |
0.3 | 1.8 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.3 | 1.2 | GO:0051697 | protein delipidation(GO:0051697) |
0.3 | 0.9 | GO:0010288 | response to lead ion(GO:0010288) |
0.3 | 0.9 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.3 | 1.5 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.3 | 0.6 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.3 | 0.9 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.3 | 0.9 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.3 | 2.3 | GO:0002084 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.3 | 1.2 | GO:1902475 | L-glutamate transmembrane transport(GO:0089711) L-alpha-amino acid transmembrane transport(GO:1902475) |
0.3 | 0.6 | GO:0002840 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
0.3 | 2.0 | GO:0060736 | prostate gland growth(GO:0060736) |
0.3 | 0.6 | GO:0001710 | mesodermal cell fate commitment(GO:0001710) |
0.3 | 24.4 | GO:0071805 | cellular potassium ion transport(GO:0071804) potassium ion transmembrane transport(GO:0071805) |
0.3 | 0.3 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
0.3 | 0.3 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
0.3 | 0.8 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.3 | 0.8 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
0.3 | 0.3 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.3 | 0.3 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
0.3 | 1.3 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.3 | 0.8 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
0.3 | 2.1 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.3 | 0.8 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.3 | 4.0 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.3 | 0.8 | GO:1904220 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.3 | 0.3 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
0.3 | 1.8 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.3 | 2.1 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.3 | 0.3 | GO:0072038 | mesenchymal stem cell maintenance involved in nephron morphogenesis(GO:0072038) |
0.3 | 1.3 | GO:1903894 | regulation of IRE1-mediated unfolded protein response(GO:1903894) |
0.3 | 1.8 | GO:0035418 | protein localization to synapse(GO:0035418) |
0.3 | 0.5 | GO:0003228 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
0.3 | 1.5 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.3 | 7.1 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.2 | 0.7 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
0.2 | 0.7 | GO:0099601 | regulation of neurotransmitter receptor activity(GO:0099601) |
0.2 | 2.0 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.2 | 0.5 | GO:0060166 | olfactory pit development(GO:0060166) |
0.2 | 0.2 | GO:0060459 | left lung development(GO:0060459) |
0.2 | 1.2 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
0.2 | 0.5 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.2 | 1.0 | GO:0014889 | muscle atrophy(GO:0014889) |
0.2 | 0.5 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.2 | 0.2 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
0.2 | 1.0 | GO:2000479 | regulation of cAMP-dependent protein kinase activity(GO:2000479) |
0.2 | 1.0 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.2 | 0.2 | GO:2000587 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.2 | 0.9 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.2 | 0.7 | GO:0010870 | positive regulation of receptor biosynthetic process(GO:0010870) |
0.2 | 1.4 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.2 | 2.6 | GO:0036065 | fucosylation(GO:0036065) |
0.2 | 0.5 | GO:0060513 | prostatic bud formation(GO:0060513) |
0.2 | 1.9 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.2 | 0.2 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
0.2 | 0.2 | GO:0032627 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) |
0.2 | 2.2 | GO:0007270 | neuron-neuron synaptic transmission(GO:0007270) |
0.2 | 0.7 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.2 | 0.7 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.2 | 2.9 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
0.2 | 0.4 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.2 | 2.2 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.2 | 1.3 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.2 | 0.9 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.2 | 0.2 | GO:0072393 | microtubule anchoring at microtubule organizing center(GO:0072393) |
0.2 | 1.1 | GO:0042160 | lipoprotein modification(GO:0042160) lipoprotein oxidation(GO:0042161) |
0.2 | 2.8 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.2 | 0.6 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.2 | 0.2 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.2 | 0.6 | GO:0003383 | apical constriction(GO:0003383) |
0.2 | 0.8 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.2 | 0.6 | GO:0009212 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
0.2 | 0.2 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
0.2 | 0.6 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.2 | 0.6 | GO:2001201 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.2 | 0.6 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.2 | 5.6 | GO:0008542 | visual learning(GO:0008542) |
0.2 | 0.6 | GO:0060437 | lung growth(GO:0060437) |
0.2 | 1.0 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
0.2 | 0.2 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) |
0.2 | 0.2 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.2 | 0.2 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.2 | 0.2 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
0.2 | 0.8 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.2 | 0.8 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.2 | 4.1 | GO:0007340 | acrosome reaction(GO:0007340) |
0.2 | 5.5 | GO:0006813 | potassium ion transport(GO:0006813) |
0.2 | 7.0 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
0.2 | 0.6 | GO:2000520 | regulation of immunological synapse formation(GO:2000520) |
0.2 | 1.4 | GO:1902855 | regulation of nonmotile primary cilium assembly(GO:1902855) |
0.2 | 0.6 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.2 | 0.2 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.2 | 0.8 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.2 | 1.3 | GO:1990403 | embryonic brain development(GO:1990403) |
0.2 | 0.4 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.2 | 0.4 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.2 | 0.2 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.2 | 0.6 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.2 | 1.3 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.2 | 0.7 | GO:0060291 | long-term synaptic potentiation(GO:0060291) |
0.2 | 0.4 | GO:1903998 | regulation of eating behavior(GO:1903998) |
0.2 | 0.9 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.2 | 0.2 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
0.2 | 0.7 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.2 | 0.2 | GO:0071673 | positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
0.2 | 0.4 | GO:0060157 | urinary bladder development(GO:0060157) |
0.2 | 1.4 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.2 | 0.5 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.2 | 0.4 | GO:0060872 | semicircular canal development(GO:0060872) |
0.2 | 0.2 | GO:0021557 | oculomotor nerve development(GO:0021557) |
0.2 | 1.9 | GO:0045056 | transcytosis(GO:0045056) |
0.2 | 0.5 | GO:0006208 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.2 | 1.2 | GO:0060074 | synapse maturation(GO:0060074) |
0.2 | 0.7 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.2 | 1.4 | GO:0008347 | glial cell migration(GO:0008347) |
0.2 | 0.5 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.2 | 1.5 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.2 | 0.8 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.2 | 0.2 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
0.2 | 2.6 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.2 | 0.5 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.2 | 0.3 | GO:2000410 | thymocyte migration(GO:0072679) regulation of thymocyte migration(GO:2000410) positive regulation of thymocyte migration(GO:2000412) |
0.2 | 1.3 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.2 | 0.5 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.2 | 0.5 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.2 | 0.3 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
0.2 | 0.2 | GO:0036492 | regulation of translation in response to endoplasmic reticulum stress(GO:0036490) regulation of translation initiation in response to endoplasmic reticulum stress(GO:0036491) eiF2alpha phosphorylation in response to endoplasmic reticulum stress(GO:0036492) |
0.2 | 0.3 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.2 | 0.3 | GO:0086036 | regulation of cardiac muscle cell membrane potential(GO:0086036) |
0.2 | 0.8 | GO:0016322 | neuron remodeling(GO:0016322) |
0.2 | 0.2 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.2 | 2.0 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.2 | 0.3 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.2 | 0.2 | GO:0090325 | regulation of locomotion involved in locomotory behavior(GO:0090325) |
0.2 | 0.8 | GO:0009115 | xanthine catabolic process(GO:0009115) |
0.2 | 0.6 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.2 | 0.5 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.2 | 0.6 | GO:0034239 | regulation of macrophage fusion(GO:0034239) |
0.1 | 0.6 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
0.1 | 0.3 | GO:2001225 | regulation of chloride transport(GO:2001225) |
0.1 | 0.3 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
0.1 | 0.9 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.1 | 0.6 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.1 | 0.7 | GO:0021511 | spinal cord patterning(GO:0021511) |
0.1 | 0.3 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.1 | 0.7 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.1 | 0.4 | GO:0001302 | replicative cell aging(GO:0001302) |
0.1 | 0.4 | GO:0015889 | cobalamin transport(GO:0015889) |
0.1 | 0.1 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
0.1 | 0.4 | GO:0018343 | protein farnesylation(GO:0018343) |
0.1 | 0.7 | GO:0061042 | vascular wound healing(GO:0061042) |
0.1 | 1.3 | GO:0047496 | vesicle transport along microtubule(GO:0047496) |
0.1 | 0.6 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.1 | 0.3 | GO:0090238 | positive regulation of arachidonic acid secretion(GO:0090238) |
0.1 | 0.3 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
0.1 | 0.8 | GO:0015884 | folic acid transport(GO:0015884) |
0.1 | 0.1 | GO:0030432 | peristalsis(GO:0030432) |
0.1 | 0.1 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
0.1 | 2.5 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.1 | 0.3 | GO:0001969 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
0.1 | 0.4 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.1 | 0.8 | GO:0019226 | transmission of nerve impulse(GO:0019226) |
0.1 | 0.3 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.1 | 1.3 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.1 | 0.3 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
0.1 | 0.7 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.1 | 0.7 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
0.1 | 0.3 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.1 | 0.7 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.1 | 0.4 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.1 | 0.7 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.1 | 0.4 | GO:0070662 | mast cell proliferation(GO:0070662) regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
0.1 | 0.8 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.1 | 0.3 | GO:0002767 | immune response-inhibiting signal transduction(GO:0002765) immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.1 | 0.3 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.1 | 0.4 | GO:1901874 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.1 | 0.1 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.1 | 0.1 | GO:0006533 | aspartate catabolic process(GO:0006533) |
0.1 | 1.3 | GO:0051642 | centrosome localization(GO:0051642) |
0.1 | 3.5 | GO:0046847 | filopodium assembly(GO:0046847) |
0.1 | 0.4 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.1 | 0.5 | GO:0051639 | actin filament network formation(GO:0051639) |
0.1 | 1.5 | GO:0021954 | central nervous system neuron development(GO:0021954) |
0.1 | 0.5 | GO:1900864 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.1 | 0.3 | GO:0071798 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.1 | 4.9 | GO:0035773 | insulin secretion involved in cellular response to glucose stimulus(GO:0035773) |
0.1 | 0.2 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.1 | 0.4 | GO:0061590 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylserine scrambling(GO:0061589) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
0.1 | 0.1 | GO:0042427 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
0.1 | 1.1 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.1 | 0.5 | GO:0032202 | telomere assembly(GO:0032202) |
0.1 | 0.8 | GO:0002485 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
0.1 | 0.4 | GO:1903232 | melanosome assembly(GO:1903232) |
0.1 | 1.3 | GO:0003334 | keratinocyte development(GO:0003334) |
0.1 | 2.0 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
0.1 | 0.5 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.1 | 0.4 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.1 | 0.2 | GO:0001696 | gastric acid secretion(GO:0001696) |
0.1 | 0.2 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.1 | 0.4 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.1 | 0.2 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.1 | 0.2 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
0.1 | 0.6 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.1 | 0.3 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.1 | 0.3 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.1 | 0.5 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.1 | 0.3 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.1 | 2.2 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.1 | 0.2 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.1 | 0.8 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.1 | 0.1 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.1 | 0.1 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.1 | 0.2 | GO:0034139 | regulation of toll-like receptor 3 signaling pathway(GO:0034139) |
0.1 | 0.3 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.1 | 1.7 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.1 | 0.4 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
0.1 | 0.4 | GO:0035627 | ceramide transport(GO:0035627) |
0.1 | 0.1 | GO:0001975 | response to amphetamine(GO:0001975) |
0.1 | 0.3 | GO:0046049 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.1 | 0.1 | GO:0061622 | glycolytic process through glucose-1-phosphate(GO:0061622) |
0.1 | 0.1 | GO:0007442 | hindgut morphogenesis(GO:0007442) |
0.1 | 0.3 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
0.1 | 0.1 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.1 | 0.5 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
0.1 | 0.5 | GO:0051798 | positive regulation of hair follicle development(GO:0051798) |
0.1 | 0.1 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.1 | 1.4 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.1 | 1.3 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.1 | 0.6 | GO:0033683 | nucleotide-excision repair, DNA incision(GO:0033683) |
0.1 | 1.5 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 1.0 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.1 | 0.2 | GO:0035864 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.1 | 0.1 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.1 | 0.3 | GO:1900102 | negative regulation of endoplasmic reticulum unfolded protein response(GO:1900102) |
0.1 | 0.2 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.1 | 0.2 | GO:0010993 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
0.1 | 0.2 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
0.1 | 0.8 | GO:0046579 | positive regulation of Ras protein signal transduction(GO:0046579) |
0.1 | 0.3 | GO:0042637 | catagen(GO:0042637) |
0.1 | 0.4 | GO:0034627 | 'de novo' NAD biosynthetic process(GO:0034627) |
0.1 | 0.3 | GO:2000668 | dendritic cell apoptotic process(GO:0097048) regulation of dendritic cell apoptotic process(GO:2000668) |
0.1 | 2.8 | GO:0002028 | regulation of sodium ion transport(GO:0002028) |
0.1 | 0.1 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.1 | 0.1 | GO:0042713 | sperm ejaculation(GO:0042713) |
0.1 | 0.1 | GO:0072198 | mesenchymal cell proliferation involved in ureter development(GO:0072198) regulation of mesenchymal cell proliferation involved in ureter development(GO:0072199) |
0.1 | 0.5 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.1 | 0.2 | GO:0014717 | regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014717) satellite cell activation involved in skeletal muscle regeneration(GO:0014901) |
0.1 | 0.3 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.1 | 0.1 | GO:0072143 | mesangial cell differentiation(GO:0072007) glomerular mesangial cell differentiation(GO:0072008) kidney interstitial fibroblast differentiation(GO:0072071) renal interstitial fibroblast development(GO:0072141) mesangial cell development(GO:0072143) glomerular mesangial cell development(GO:0072144) |
0.1 | 0.3 | GO:1903626 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
0.1 | 0.3 | GO:0045423 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
0.1 | 1.2 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.1 | 0.3 | GO:0035878 | nail development(GO:0035878) |
0.1 | 0.1 | GO:0002681 | somatic diversification of T cell receptor genes(GO:0002568) somatic recombination of T cell receptor gene segments(GO:0002681) T cell receptor V(D)J recombination(GO:0033153) |
0.1 | 0.2 | GO:0009750 | response to fructose(GO:0009750) |
0.1 | 0.3 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.1 | 0.1 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
0.1 | 0.3 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.1 | 0.2 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.1 | 0.3 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.1 | 0.2 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.1 | 0.2 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.1 | 0.1 | GO:2000172 | regulation of branching morphogenesis of a nerve(GO:2000172) |
0.1 | 0.4 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.1 | 0.7 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.1 | 0.2 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.1 | 0.9 | GO:0021987 | cerebral cortex development(GO:0021987) |
0.1 | 0.2 | GO:1902267 | polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) |
0.1 | 0.5 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.1 | 0.1 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
0.1 | 0.1 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
0.1 | 0.2 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.1 | 0.2 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.1 | 0.2 | GO:0021854 | hypothalamus development(GO:0021854) |
0.1 | 0.2 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) |
0.1 | 0.1 | GO:1902896 | terminal web assembly(GO:1902896) |
0.1 | 0.2 | GO:0032056 | positive regulation of translation in response to stress(GO:0032056) positive regulation of translational initiation in response to stress(GO:0032058) |
0.1 | 0.1 | GO:0015705 | iodide transport(GO:0015705) |
0.1 | 0.2 | GO:0051466 | positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
0.1 | 0.2 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
0.1 | 0.6 | GO:0051926 | negative regulation of calcium ion transport(GO:0051926) |
0.1 | 0.2 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.1 | 0.1 | GO:0070253 | somatostatin secretion(GO:0070253) |
0.1 | 1.3 | GO:0034394 | protein localization to cell surface(GO:0034394) |
0.1 | 0.2 | GO:0043586 | tongue development(GO:0043586) |
0.1 | 3.1 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.1 | 0.1 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
0.1 | 0.4 | GO:0070633 | transepithelial transport(GO:0070633) |
0.1 | 0.4 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.1 | 0.1 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.1 | 0.1 | GO:0035984 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.1 | 0.5 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.1 | 0.3 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.1 | 0.2 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.1 | 0.1 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.1 | 0.1 | GO:0033087 | negative regulation of immature T cell proliferation(GO:0033087) |
0.1 | 2.6 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.1 | 0.2 | GO:0043313 | regulation of neutrophil degranulation(GO:0043313) |
0.1 | 0.6 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.1 | 0.4 | GO:0016266 | O-glycan processing(GO:0016266) |
0.1 | 0.5 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.1 | 0.1 | GO:0010578 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.1 | 0.1 | GO:1902262 | apoptotic process involved in patterning of blood vessels(GO:1902262) |
0.1 | 0.4 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.1 | 0.1 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.1 | 0.3 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.1 | 0.1 | GO:0061046 | regulation of branching involved in lung morphogenesis(GO:0061046) |
0.1 | 0.2 | GO:0071236 | cellular response to antibiotic(GO:0071236) |
0.1 | 0.2 | GO:0051031 | tRNA transport(GO:0051031) |
0.1 | 0.1 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.1 | 0.1 | GO:0009128 | purine nucleoside monophosphate catabolic process(GO:0009128) |
0.1 | 1.9 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.1 | 0.2 | GO:1902990 | mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
0.1 | 0.1 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.1 | 0.1 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.1 | 0.1 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.1 | 0.1 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.1 | 0.2 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.1 | 0.1 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.1 | 0.2 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
0.1 | 0.1 | GO:0002727 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.0 | 0.0 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.0 | 0.2 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.0 | 0.0 | GO:0046083 | adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
0.0 | 0.1 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.0 | 0.2 | GO:0001771 | immunological synapse formation(GO:0001771) |
0.0 | 0.0 | GO:0045356 | positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
0.0 | 0.3 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.0 | 0.1 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
0.0 | 0.3 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.0 | 0.2 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
0.0 | 0.1 | GO:0045829 | negative regulation of isotype switching(GO:0045829) |
0.0 | 2.3 | GO:0006836 | neurotransmitter transport(GO:0006836) |
0.0 | 0.3 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.0 | 0.1 | GO:0060004 | reflex(GO:0060004) |
0.0 | 0.1 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.0 | 0.4 | GO:0030539 | male genitalia development(GO:0030539) |
0.0 | 0.1 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.0 | 0.0 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
0.0 | 0.1 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.0 | 0.3 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.0 | 0.0 | GO:0008354 | germ cell migration(GO:0008354) |
0.0 | 0.0 | GO:0001826 | inner cell mass cell differentiation(GO:0001826) |
0.0 | 0.2 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
0.0 | 0.0 | GO:0035933 | glucocorticoid secretion(GO:0035933) regulation of glucocorticoid secretion(GO:2000849) |
0.0 | 0.2 | GO:0014002 | astrocyte development(GO:0014002) |
0.0 | 0.0 | GO:1901256 | macrophage colony-stimulating factor production(GO:0036301) granulocyte colony-stimulating factor production(GO:0071611) regulation of granulocyte colony-stimulating factor production(GO:0071655) regulation of macrophage colony-stimulating factor production(GO:1901256) |
0.0 | 0.1 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.0 | 0.1 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.0 | 0.0 | GO:0017085 | response to insecticide(GO:0017085) |
0.0 | 0.3 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.0 | 0.1 | GO:0048853 | forebrain morphogenesis(GO:0048853) |
0.0 | 0.1 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.0 | 0.2 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.0 | 0.0 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.0 | 0.1 | GO:0010988 | regulation of low-density lipoprotein particle clearance(GO:0010988) |
0.0 | 0.1 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.0 | 0.1 | GO:0033227 | dsRNA transport(GO:0033227) |
0.0 | 0.2 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.0 | 0.1 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.0 | 0.0 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.0 | 0.0 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.0 | 0.3 | GO:0070862 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.0 | 0.0 | GO:0045080 | positive regulation of chemokine biosynthetic process(GO:0045080) |
0.0 | 0.1 | GO:0046379 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.0 | 0.1 | GO:0034184 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.0 | 0.1 | GO:0001842 | neural fold formation(GO:0001842) |
0.0 | 0.2 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.0 | 0.0 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
0.0 | 0.1 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.0 | 0.1 | GO:0002325 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.0 | 0.1 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.0 | 0.0 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
0.0 | 0.0 | GO:0010725 | regulation of primitive erythrocyte differentiation(GO:0010725) |
0.0 | 0.1 | GO:1903772 | regulation of viral budding via host ESCRT complex(GO:1903772) |
0.0 | 0.0 | GO:0045324 | late endosome to vacuole transport(GO:0045324) |
0.0 | 0.2 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.0 | 0.1 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.0 | 0.0 | GO:1900112 | regulation of histone H3-K9 trimethylation(GO:1900112) |
0.0 | 0.0 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.0 | 0.1 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.0 | 0.2 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.0 | 0.0 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
0.0 | 0.4 | GO:0032835 | glomerulus development(GO:0032835) |
0.0 | 0.3 | GO:0044550 | secondary metabolite biosynthetic process(GO:0044550) |
0.0 | 0.2 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.0 | 0.2 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.0 | 0.0 | GO:0038001 | paracrine signaling(GO:0038001) |
0.0 | 0.0 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.0 | 0.0 | GO:0072203 | cell proliferation involved in metanephros development(GO:0072203) |
0.0 | 0.0 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
0.0 | 0.1 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
0.0 | 0.1 | GO:0042346 | positive regulation of NF-kappaB import into nucleus(GO:0042346) |
0.0 | 0.1 | GO:0007215 | glutamate receptor signaling pathway(GO:0007215) |
0.0 | 0.1 | GO:0070269 | pyroptosis(GO:0070269) |
0.0 | 0.0 | GO:0051410 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.0 | 0.1 | GO:0006311 | meiotic gene conversion(GO:0006311) gene conversion(GO:0035822) |
0.0 | 0.0 | GO:2000380 | regulation of mesoderm development(GO:2000380) negative regulation of mesoderm development(GO:2000381) |
0.0 | 0.1 | GO:0006265 | DNA topological change(GO:0006265) |
0.0 | 0.0 | GO:0071694 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.0 | 0.0 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.0 | 0.1 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.0 | 0.1 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.0 | 0.0 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.0 | 0.1 | GO:0030647 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.0 | 0.0 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.0 | 0.0 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.0 | 0.0 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) |
0.0 | 0.1 | GO:0042407 | cristae formation(GO:0042407) |
0.0 | 0.0 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
0.0 | 0.0 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
0.0 | 0.2 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.0 | 0.0 | GO:0060789 | hair follicle placode formation(GO:0060789) |
0.0 | 0.0 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.0 | 0.2 | GO:0001895 | retina homeostasis(GO:0001895) |
0.0 | 0.0 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
0.0 | 0.0 | GO:2000343 | positive regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000343) |
0.0 | 0.0 | GO:0001757 | somite specification(GO:0001757) |
0.0 | 0.0 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.4 | 10.2 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
2.8 | 14.2 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
2.4 | 7.1 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
2.3 | 11.5 | GO:0097433 | dense body(GO:0097433) |
2.2 | 22.2 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
2.2 | 2.2 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
2.1 | 6.2 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
1.9 | 7.8 | GO:0045298 | tubulin complex(GO:0045298) |
1.8 | 7.1 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
1.7 | 11.9 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
1.6 | 16.5 | GO:0035253 | ciliary rootlet(GO:0035253) |
1.5 | 3.1 | GO:0033647 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
1.5 | 18.4 | GO:0043194 | axon initial segment(GO:0043194) |
1.5 | 4.5 | GO:0097441 | basilar dendrite(GO:0097441) |
1.5 | 11.7 | GO:0043083 | synaptic cleft(GO:0043083) |
1.5 | 5.9 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
1.3 | 6.7 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
1.3 | 97.5 | GO:0030175 | filopodium(GO:0030175) |
1.2 | 8.7 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
1.2 | 21.0 | GO:0030673 | axolemma(GO:0030673) |
1.1 | 3.4 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
1.1 | 3.4 | GO:0000322 | storage vacuole(GO:0000322) |
1.1 | 5.5 | GO:0000235 | astral microtubule(GO:0000235) |
1.1 | 26.1 | GO:0048786 | presynaptic active zone(GO:0048786) |
1.0 | 7.2 | GO:0097449 | astrocyte projection(GO:0097449) |
1.0 | 1.9 | GO:1990635 | proximal dendrite(GO:1990635) |
1.0 | 16.5 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.9 | 27.9 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.9 | 2.8 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.9 | 1.8 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.8 | 5.1 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.8 | 5.8 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.8 | 6.6 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.8 | 4.9 | GO:0016012 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.8 | 1.6 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.8 | 3.1 | GO:1990696 | USH2 complex(GO:1990696) |
0.8 | 7.7 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.8 | 3.8 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.8 | 1.5 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.8 | 12.8 | GO:0005614 | interstitial matrix(GO:0005614) |
0.7 | 1.4 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.7 | 9.5 | GO:0031045 | dense core granule(GO:0031045) |
0.6 | 0.6 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.6 | 3.8 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.6 | 1.8 | GO:0042583 | chromaffin granule(GO:0042583) |
0.6 | 1.8 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.6 | 1.8 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.6 | 3.0 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
0.6 | 2.3 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.6 | 4.5 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.6 | 3.9 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.6 | 12.9 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.5 | 3.3 | GO:0043198 | dendritic shaft(GO:0043198) |
0.5 | 1.6 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.5 | 1.5 | GO:0036396 | MIS complex(GO:0036396) |
0.5 | 2.9 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.5 | 3.3 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.5 | 11.8 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.5 | 1.4 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.5 | 1.8 | GO:0030478 | actin cap(GO:0030478) |
0.5 | 11.3 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.4 | 8.3 | GO:0032589 | neuron projection membrane(GO:0032589) |
0.4 | 1.3 | GO:1990393 | 3M complex(GO:1990393) |
0.4 | 1.7 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.4 | 1.7 | GO:0033268 | node of Ranvier(GO:0033268) |
0.4 | 1.2 | GO:0071942 | XPC complex(GO:0071942) |
0.4 | 4.9 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.4 | 1.2 | GO:0048179 | activin receptor complex(GO:0048179) |
0.4 | 1.2 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.4 | 5.2 | GO:0043196 | varicosity(GO:0043196) |
0.4 | 36.6 | GO:0014069 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
0.4 | 4.3 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.4 | 18.7 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.4 | 3.4 | GO:0097440 | apical dendrite(GO:0097440) |
0.4 | 3.4 | GO:0060076 | excitatory synapse(GO:0060076) |
0.4 | 49.4 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.4 | 2.5 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.4 | 2.5 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.4 | 2.9 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.4 | 1.1 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.4 | 2.1 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.4 | 2.1 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.4 | 1.4 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.3 | 1.0 | GO:0033010 | paranodal junction(GO:0033010) |
0.3 | 0.7 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.3 | 1.6 | GO:0005579 | membrane attack complex(GO:0005579) |
0.3 | 0.9 | GO:0017133 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.3 | 10.2 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.3 | 7.9 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.3 | 2.6 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.3 | 2.0 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.3 | 1.7 | GO:0016589 | NURF complex(GO:0016589) |
0.3 | 3.6 | GO:0044295 | axonal growth cone(GO:0044295) |
0.3 | 0.8 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.3 | 1.3 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.3 | 0.8 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.3 | 0.5 | GO:0055087 | Ski complex(GO:0055087) |
0.2 | 0.7 | GO:0042567 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.2 | 1.0 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.2 | 4.0 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.2 | 0.9 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.2 | 1.1 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.2 | 1.8 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.2 | 0.8 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.2 | 2.1 | GO:0098827 | endoplasmic reticulum subcompartment(GO:0098827) |
0.2 | 0.8 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.2 | 0.6 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.2 | 2.1 | GO:0042555 | MCM complex(GO:0042555) |
0.2 | 0.6 | GO:0032437 | cuticular plate(GO:0032437) |
0.2 | 0.9 | GO:0005883 | neurofilament(GO:0005883) |
0.2 | 0.2 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.2 | 0.6 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.2 | 0.4 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.2 | 0.7 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.2 | 0.5 | GO:0071797 | LUBAC complex(GO:0071797) |
0.2 | 0.4 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.2 | 0.7 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.2 | 2.1 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.2 | 6.8 | GO:0043197 | dendritic spine(GO:0043197) |
0.2 | 10.8 | GO:0030426 | growth cone(GO:0030426) |
0.2 | 1.3 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.2 | 1.1 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.2 | 0.6 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.2 | 1.7 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.2 | 0.6 | GO:0070545 | PeBoW complex(GO:0070545) |
0.1 | 0.3 | GO:0097470 | ribbon synapse(GO:0097470) |
0.1 | 0.1 | GO:0044309 | neuron spine(GO:0044309) |
0.1 | 0.4 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.1 | 0.3 | GO:0071203 | WASH complex(GO:0071203) |
0.1 | 0.7 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.1 | 0.7 | GO:0002177 | manchette(GO:0002177) |
0.1 | 0.3 | GO:0072534 | perineuronal net(GO:0072534) |
0.1 | 0.8 | GO:0070847 | core mediator complex(GO:0070847) |
0.1 | 0.3 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.1 | 1.5 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.1 | 0.1 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.1 | 0.7 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.1 | 0.3 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
0.1 | 0.9 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
0.1 | 0.7 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.1 | 1.9 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.1 | 1.8 | GO:0071012 | catalytic step 1 spliceosome(GO:0071012) |
0.1 | 0.1 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.1 | 0.6 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.1 | 0.7 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.1 | 0.6 | GO:0061617 | MICOS complex(GO:0061617) |
0.1 | 0.5 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.1 | 0.4 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.1 | 2.3 | GO:0030686 | 90S preribosome(GO:0030686) |
0.1 | 0.6 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 0.1 | GO:0035838 | growing cell tip(GO:0035838) |
0.1 | 1.4 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.1 | 0.1 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.1 | 0.3 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.1 | 6.1 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 0.7 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.1 | 0.2 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.1 | 1.2 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 0.5 | GO:0071547 | piP-body(GO:0071547) |
0.1 | 0.3 | GO:0044299 | C-fiber(GO:0044299) |
0.1 | 0.5 | GO:0031209 | SCAR complex(GO:0031209) |
0.1 | 0.5 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.1 | 0.3 | GO:0035363 | histone locus body(GO:0035363) |
0.1 | 0.6 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.1 | 0.1 | GO:1990357 | terminal web(GO:1990357) |
0.1 | 2.8 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.1 | 1.1 | GO:0043679 | axon terminus(GO:0043679) |
0.1 | 1.1 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.1 | 0.5 | GO:0000124 | SAGA complex(GO:0000124) |
0.1 | 0.2 | GO:0097422 | tubular endosome(GO:0097422) |
0.1 | 0.2 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.1 | 0.3 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.1 | 0.4 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.1 | 0.1 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.1 | 0.1 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.1 | 0.2 | GO:0098536 | deuterosome(GO:0098536) |
0.1 | 0.6 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.0 | 0.2 | GO:0097651 | phosphatidylinositol 3-kinase complex, class I(GO:0097651) |
0.0 | 0.3 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.0 | 0.1 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.0 | 0.4 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.0 | 2.1 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 10.0 | GO:0045202 | synapse(GO:0045202) |
0.0 | 0.2 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.0 | 0.4 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.0 | 0.2 | GO:0070876 | SOSS complex(GO:0070876) |
0.0 | 0.1 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.0 | 0.5 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 0.2 | GO:0030681 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.0 | 0.4 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.0 | 0.6 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.0 | 0.2 | GO:0071439 | clathrin complex(GO:0071439) |
0.0 | 0.2 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.0 | 0.4 | GO:0070382 | exocytic vesicle(GO:0070382) |
0.0 | 0.0 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.0 | 0.2 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.0 | 0.1 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.0 | 3.1 | GO:0043209 | myelin sheath(GO:0043209) |
0.0 | 0.2 | GO:0034464 | BBSome(GO:0034464) |
0.0 | 0.1 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.0 | 0.1 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.0 | 0.1 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.0 | 0.1 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.0 | 0.3 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.0 | 0.1 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.0 | 0.1 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.0 | 0.0 | GO:0097386 | glial cell projection(GO:0097386) |
0.0 | 0.1 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.0 | 0.0 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.0 | 0.0 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.0 | 0.0 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.0 | 0.1 | GO:0005838 | proteasome regulatory particle(GO:0005838) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.7 | 18.5 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
3.4 | 10.1 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
3.4 | 13.5 | GO:0032051 | clathrin light chain binding(GO:0032051) |
3.3 | 10.0 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
3.1 | 12.5 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
2.8 | 8.5 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
2.8 | 5.6 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
2.2 | 11.2 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
2.2 | 6.7 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
2.2 | 6.7 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
2.2 | 8.7 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
2.1 | 10.7 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
2.0 | 10.0 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
1.7 | 6.8 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
1.7 | 6.7 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
1.6 | 4.9 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
1.6 | 8.0 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
1.5 | 6.0 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
1.5 | 29.6 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
1.5 | 2.9 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
1.4 | 5.8 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
1.4 | 4.3 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
1.3 | 5.4 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
1.3 | 4.0 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
1.3 | 3.8 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
1.2 | 83.0 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
1.2 | 32.3 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
1.1 | 5.7 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
1.1 | 8.0 | GO:0050897 | cobalt ion binding(GO:0050897) |
1.1 | 3.3 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
1.1 | 6.6 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
1.1 | 13.8 | GO:0050811 | GABA receptor binding(GO:0050811) |
1.0 | 4.2 | GO:0005042 | netrin receptor activity(GO:0005042) |
1.0 | 3.1 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
1.0 | 6.1 | GO:0004385 | guanylate kinase activity(GO:0004385) |
1.0 | 3.1 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
1.0 | 1.0 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
1.0 | 7.1 | GO:0102337 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
1.0 | 6.1 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
1.0 | 3.0 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
1.0 | 4.0 | GO:0016151 | nickel cation binding(GO:0016151) |
1.0 | 3.0 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
1.0 | 4.9 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
1.0 | 2.9 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
1.0 | 7.6 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
1.0 | 9.5 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.9 | 3.8 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.9 | 12.3 | GO:0031005 | filamin binding(GO:0031005) |
0.9 | 2.8 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.9 | 13.1 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.9 | 2.7 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.9 | 8.1 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.9 | 4.5 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.9 | 8.0 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.8 | 2.5 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.8 | 1.6 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.8 | 2.4 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.8 | 0.8 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.8 | 4.0 | GO:0051429 | corticotropin-releasing hormone receptor binding(GO:0051429) |
0.8 | 0.8 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.8 | 0.8 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.8 | 4.7 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.8 | 5.5 | GO:0003680 | AT DNA binding(GO:0003680) |
0.8 | 2.3 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.8 | 3.1 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.8 | 3.0 | GO:0051425 | PTB domain binding(GO:0051425) |
0.7 | 3.0 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.7 | 23.7 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.7 | 1.5 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.7 | 0.7 | GO:0009374 | biotin binding(GO:0009374) |
0.7 | 10.2 | GO:0016917 | GABA receptor activity(GO:0016917) |
0.7 | 2.9 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.7 | 3.5 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.7 | 5.6 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.7 | 2.1 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.7 | 2.0 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
0.7 | 2.0 | GO:0089720 | caspase binding(GO:0089720) |
0.7 | 2.7 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.7 | 4.6 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.7 | 4.6 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.6 | 3.2 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.6 | 9.7 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.6 | 3.2 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.6 | 1.9 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.6 | 1.9 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.6 | 0.6 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
0.6 | 3.0 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.6 | 1.8 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.6 | 1.8 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.6 | 8.0 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.6 | 1.7 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.5 | 3.8 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.5 | 3.8 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.5 | 8.1 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.5 | 8.1 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.5 | 6.4 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.5 | 2.1 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.5 | 5.3 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.5 | 1.6 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.5 | 2.6 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.5 | 3.1 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.5 | 0.5 | GO:0043855 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) intracellular cGMP activated cation channel activity(GO:0005223) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.5 | 5.6 | GO:0005522 | profilin binding(GO:0005522) |
0.5 | 4.1 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.5 | 3.1 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.5 | 2.0 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.5 | 1.5 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.5 | 3.5 | GO:0005416 | cation:amino acid symporter activity(GO:0005416) |
0.5 | 3.5 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.5 | 1.5 | GO:0051373 | FATZ binding(GO:0051373) |
0.5 | 3.5 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.5 | 1.5 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.5 | 0.5 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.5 | 3.8 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.5 | 1.9 | GO:0070052 | collagen V binding(GO:0070052) |
0.5 | 0.9 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.5 | 1.4 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
0.4 | 0.9 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.4 | 2.2 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.4 | 1.3 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.4 | 6.2 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.4 | 1.3 | GO:0035939 | microsatellite binding(GO:0035939) |
0.4 | 7.1 | GO:0022842 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
0.4 | 4.4 | GO:0051378 | serotonin binding(GO:0051378) |
0.4 | 3.0 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.4 | 2.2 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.4 | 0.9 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.4 | 15.1 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.4 | 3.9 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.4 | 1.7 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.4 | 1.3 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.4 | 1.3 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.4 | 1.6 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.4 | 1.2 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.4 | 2.0 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.4 | 1.2 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.4 | 5.1 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.4 | 2.3 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.4 | 11.5 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.4 | 5.0 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.4 | 1.1 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.4 | 4.5 | GO:0043733 | alkylbase DNA N-glycosylase activity(GO:0003905) DNA-3-methylbase glycosylase activity(GO:0043733) |
0.4 | 1.1 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.4 | 1.8 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.4 | 3.6 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.4 | 0.7 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.4 | 1.1 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
0.3 | 3.8 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.3 | 0.3 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.3 | 1.4 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.3 | 1.0 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.3 | 2.4 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.3 | 0.7 | GO:0030519 | snoRNP binding(GO:0030519) |
0.3 | 7.4 | GO:0004629 | phospholipase C activity(GO:0004629) |
0.3 | 2.0 | GO:0030506 | ankyrin binding(GO:0030506) |
0.3 | 1.3 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.3 | 1.6 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.3 | 3.9 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.3 | 11.2 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
0.3 | 6.1 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.3 | 0.6 | GO:0080084 | RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) RNA polymerase III type 3 promoter DNA binding(GO:0001032) 5S rDNA binding(GO:0080084) |
0.3 | 4.4 | GO:0070402 | NADPH binding(GO:0070402) |
0.3 | 1.9 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.3 | 1.2 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.3 | 11.6 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.3 | 1.5 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.3 | 1.5 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.3 | 0.6 | GO:0097016 | L27 domain binding(GO:0097016) |
0.3 | 0.9 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.3 | 2.3 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.3 | 7.1 | GO:0030507 | spectrin binding(GO:0030507) |
0.3 | 0.8 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.3 | 0.8 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
0.3 | 0.8 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.3 | 0.5 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.3 | 2.4 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.3 | 0.5 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.3 | 0.5 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.3 | 0.8 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.3 | 1.0 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.2 | 4.9 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.2 | 2.2 | GO:0015172 | L-glutamate transmembrane transporter activity(GO:0005313) acidic amino acid transmembrane transporter activity(GO:0015172) |
0.2 | 1.9 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.2 | 1.0 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.2 | 5.0 | GO:0030332 | cyclin binding(GO:0030332) |
0.2 | 0.5 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.2 | 1.0 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.2 | 2.1 | GO:0046977 | TAP binding(GO:0046977) |
0.2 | 1.2 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.2 | 0.9 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.2 | 1.4 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.2 | 1.8 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.2 | 1.1 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.2 | 6.4 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.2 | 0.6 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.2 | 0.6 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.2 | 1.7 | GO:0030548 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.2 | 2.3 | GO:0015643 | toxic substance binding(GO:0015643) |
0.2 | 1.1 | GO:1990254 | keratin filament binding(GO:1990254) |
0.2 | 1.1 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.2 | 0.8 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.2 | 0.6 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.2 | 0.8 | GO:0050693 | LBD domain binding(GO:0050693) |
0.2 | 0.2 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.2 | 0.6 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.2 | 0.8 | GO:0031433 | telethonin binding(GO:0031433) |
0.2 | 0.4 | GO:0034452 | dynactin binding(GO:0034452) |
0.2 | 1.8 | GO:0070513 | death domain binding(GO:0070513) |
0.2 | 1.0 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
0.2 | 0.8 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
0.2 | 0.6 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.2 | 1.5 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.2 | 12.0 | GO:0046527 | glucosyltransferase activity(GO:0046527) |
0.2 | 4.0 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.2 | 2.9 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.2 | 0.4 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.2 | 0.5 | GO:0035473 | lipase binding(GO:0035473) |
0.2 | 0.7 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.2 | 0.5 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.2 | 2.1 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.2 | 0.2 | GO:0070538 | oleic acid binding(GO:0070538) |
0.2 | 1.5 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.2 | 2.2 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
0.2 | 1.2 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.2 | 0.8 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.2 | 0.5 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.2 | 0.5 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.2 | 0.2 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.2 | 1.3 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.2 | 0.6 | GO:0005113 | patched binding(GO:0005113) |
0.2 | 0.5 | GO:0097001 | ceramide binding(GO:0097001) |
0.1 | 0.4 | GO:0004802 | transketolase activity(GO:0004802) |
0.1 | 0.3 | GO:0002046 | opsin binding(GO:0002046) |
0.1 | 0.7 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.1 | 0.7 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.1 | 1.2 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.1 | 0.4 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.1 | 0.1 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.1 | 0.8 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.1 | 0.3 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.1 | 0.4 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.1 | 0.4 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.1 | 0.5 | GO:0033265 | choline binding(GO:0033265) |
0.1 | 0.4 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.1 | 3.7 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.1 | 6.2 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.1 | 0.1 | GO:0031544 | peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.1 | 1.6 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 0.5 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.1 | 0.9 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.1 | 1.0 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.1 | 0.7 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.1 | 0.4 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.1 | 0.1 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.1 | 10.4 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.1 | 0.4 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.1 | 0.7 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.1 | 0.5 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.1 | 0.4 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.1 | 3.6 | GO:0070330 | aromatase activity(GO:0070330) |
0.1 | 0.5 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.1 | 0.5 | GO:0018812 | 3-hydroxyacyl-CoA dehydratase activity(GO:0018812) 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
0.1 | 2.5 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.1 | 0.5 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.1 | 0.6 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.1 | 0.8 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.1 | 0.3 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.1 | 0.2 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.1 | 0.4 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.1 | 1.2 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.1 | 0.3 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.1 | 0.5 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.1 | 0.6 | GO:0031419 | cobalamin binding(GO:0031419) |
0.1 | 0.6 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.1 | 0.3 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.1 | 1.9 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.1 | 0.4 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.1 | 0.3 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.1 | 1.7 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.1 | 0.4 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.1 | 0.4 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.1 | 0.8 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.1 | 0.5 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.1 | 0.1 | GO:0019958 | C-X-C chemokine binding(GO:0019958) |
0.1 | 0.1 | GO:2001070 | starch binding(GO:2001070) |
0.1 | 0.4 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.1 | 0.4 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.1 | 0.2 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.1 | 0.3 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.1 | 0.6 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.1 | 0.3 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.1 | 1.3 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
0.1 | 0.3 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.1 | 0.2 | GO:0008506 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.1 | 0.2 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.1 | 0.8 | GO:0030553 | cGMP binding(GO:0030553) |
0.1 | 0.1 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.1 | 0.2 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.1 | 0.2 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.1 | 0.5 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.1 | 0.3 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 0.7 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.1 | 0.8 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.1 | 0.9 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.1 | 0.2 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.1 | 0.3 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.1 | 0.2 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.1 | 0.3 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.1 | 0.3 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.1 | 0.3 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.1 | 0.2 | GO:2001069 | glycogen binding(GO:2001069) |
0.1 | 1.0 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.1 | 0.2 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.1 | 1.6 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.1 | 0.3 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
0.1 | 0.7 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.1 | 1.2 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.1 | 0.1 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.1 | 0.1 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.1 | 0.2 | GO:0080130 | L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
0.1 | 2.5 | GO:0043621 | protein self-association(GO:0043621) |
0.1 | 0.4 | GO:0033691 | sialic acid binding(GO:0033691) |
0.1 | 0.4 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.1 | 0.1 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.1 | 2.6 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.1 | 0.1 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.1 | 0.2 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.1 | 0.4 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 0.1 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.1 | 1.4 | GO:0019894 | kinesin binding(GO:0019894) |
0.0 | 0.2 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.0 | 0.1 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.0 | 1.0 | GO:0008081 | phosphoric diester hydrolase activity(GO:0008081) |
0.0 | 0.1 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
0.0 | 0.1 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.0 | 0.3 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.0 | 0.1 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
0.0 | 0.0 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
0.0 | 0.9 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.0 | 0.1 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.0 | 0.0 | GO:0019187 | beta-1,4-mannosyltransferase activity(GO:0019187) |
0.0 | 0.2 | GO:0004064 | arylesterase activity(GO:0004064) |
0.0 | 0.1 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.0 | 0.2 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
0.0 | 0.2 | GO:0036122 | BMP binding(GO:0036122) |
0.0 | 0.1 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.0 | 0.3 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
0.0 | 0.1 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.0 | 0.2 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.0 | 0.2 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.0 | 0.1 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.0 | 1.6 | GO:0017022 | myosin binding(GO:0017022) |
0.0 | 0.7 | GO:0030276 | clathrin binding(GO:0030276) |
0.0 | 0.4 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.0 | 0.5 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 0.1 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.0 | 0.0 | GO:0099528 | G-protein coupled neurotransmitter receptor activity(GO:0099528) |
0.0 | 0.1 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.0 | 0.1 | GO:0030619 | U1 snRNA binding(GO:0030619) |
0.0 | 0.9 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.0 | 0.1 | GO:0043199 | sulfate binding(GO:0043199) |
0.0 | 0.1 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.0 | 0.4 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.0 | 0.4 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.0 | 0.0 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.0 | 0.3 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.0 | 0.1 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.0 | 0.0 | GO:0033695 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
0.0 | 0.0 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.0 | 0.0 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.0 | 0.1 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.0 | 0.2 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.0 | 0.3 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.0 | 0.1 | GO:0002054 | nucleobase binding(GO:0002054) |
0.0 | 0.1 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.0 | 0.1 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.0 | 0.0 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.0 | 0.0 | GO:0032142 | single guanine insertion binding(GO:0032142) |
0.0 | 0.1 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.0 | 0.1 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
0.0 | 0.1 | GO:0019863 | IgE binding(GO:0019863) |
0.0 | 0.1 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.0 | 0.0 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.0 | 0.2 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.0 | 1.2 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.0 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 2.5 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.8 | 15.3 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.8 | 12.1 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.8 | 14.3 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.7 | 23.5 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.7 | 16.3 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.7 | 2.1 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.5 | 7.7 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.5 | 6.2 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.5 | 3.8 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.5 | 12.2 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.4 | 1.7 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.4 | 0.4 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.3 | 3.1 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.3 | 2.0 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.3 | 5.2 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.3 | 8.1 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.3 | 3.1 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.3 | 5.3 | PID REELIN PATHWAY | Reelin signaling pathway |
0.3 | 1.7 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.2 | 2.6 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.2 | 4.7 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.2 | 8.2 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.2 | 4.8 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.2 | 3.8 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.2 | 3.5 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.2 | 33.1 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.2 | 0.7 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.2 | 0.7 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.2 | 1.8 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 1.8 | PID SHP2 PATHWAY | SHP2 signaling |
0.1 | 0.7 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.1 | 0.4 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.1 | 3.8 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.1 | 4.0 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 2.2 | PID RAS PATHWAY | Regulation of Ras family activation |
0.1 | 0.1 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.1 | 0.1 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.1 | 4.5 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.1 | 0.4 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.1 | 0.4 | ST STAT3 PATHWAY | STAT3 Pathway |
0.1 | 0.2 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 0.6 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.1 | 0.6 | PID ARF6 PATHWAY | Arf6 signaling events |
0.1 | 0.1 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.1 | 0.1 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.1 | 0.3 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.1 | 2.2 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 0.4 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.0 | 0.1 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.0 | 0.4 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.0 | 0.4 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 0.0 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 5.0 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 0.0 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.0 | 0.0 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.0 | 0.0 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.9 | 80.2 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
1.6 | 17.5 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
1.6 | 21.9 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
1.6 | 17.2 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
1.3 | 12.6 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
1.2 | 17.9 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
1.1 | 12.0 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.9 | 6.9 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.9 | 6.0 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.8 | 1.6 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.8 | 8.1 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.7 | 30.9 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.7 | 2.9 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.7 | 2.0 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.7 | 11.2 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.7 | 17.0 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.6 | 6.9 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.6 | 6.7 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.6 | 5.2 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.6 | 7.6 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.6 | 9.3 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.6 | 1.7 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.5 | 4.3 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.5 | 12.6 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.5 | 6.0 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.5 | 6.9 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.5 | 1.5 | REACTOME ACTIVATION OF KAINATE RECEPTORS UPON GLUTAMATE BINDING | Genes involved in Activation of Kainate Receptors upon glutamate binding |
0.5 | 7.3 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.5 | 4.7 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.5 | 0.9 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.4 | 2.6 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.4 | 4.7 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.4 | 0.8 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.4 | 9.4 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.4 | 2.0 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.4 | 3.5 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.4 | 1.2 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.4 | 2.3 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.4 | 2.2 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.4 | 3.9 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.3 | 0.7 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.3 | 2.8 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.3 | 9.4 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.3 | 2.0 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.3 | 5.9 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.3 | 3.9 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.3 | 3.2 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.3 | 5.8 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.3 | 3.1 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.2 | 1.4 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.2 | 0.9 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.2 | 0.2 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.2 | 3.1 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.2 | 8.3 | REACTOME HEPARAN SULFATE HEPARIN HS GAG METABOLISM | Genes involved in Heparan sulfate/heparin (HS-GAG) metabolism |
0.2 | 5.7 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.2 | 0.8 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.2 | 1.8 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.2 | 0.2 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.2 | 2.8 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.2 | 0.2 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.2 | 3.1 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.2 | 1.0 | REACTOME SIGNALING BY NOTCH2 | Genes involved in Signaling by NOTCH2 |
0.2 | 0.7 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.2 | 0.8 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.2 | 2.8 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.2 | 1.1 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.2 | 3.5 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.2 | 3.0 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.2 | 0.3 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.2 | 0.5 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.2 | 5.3 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.2 | 2.0 | REACTOME OPIOID SIGNALLING | Genes involved in Opioid Signalling |
0.1 | 3.5 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.1 | 2.6 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.1 | 0.8 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 0.3 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.1 | 0.3 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.1 | 0.8 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.1 | 1.2 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 0.6 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.1 | 0.2 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.1 | 1.7 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.1 | 0.7 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.1 | 0.2 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.1 | 0.7 | REACTOME SIGNALLING TO RAS | Genes involved in Signalling to RAS |
0.1 | 0.1 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 0.6 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.1 | 0.4 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.1 | 0.1 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.1 | 0.1 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.1 | 0.4 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.1 | 0.3 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
0.1 | 0.2 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.1 | 0.6 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 0.5 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 0.2 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.0 | 0.5 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.0 | 0.8 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.0 | 1.1 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 0.5 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.0 | 0.2 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.0 | 0.2 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.0 | 0.3 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.0 | 1.7 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.0 | 0.2 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.0 | 0.2 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.0 | 0.3 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.0 | 0.5 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.0 | 0.3 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.0 | 2.0 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.0 | 0.2 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.0 | 0.1 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.0 | 0.1 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.0 | 0.1 | REACTOME RNA POL III TRANSCRIPTION | Genes involved in RNA Polymerase III Transcription |